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Abstract
Members within the paramyxovirus subfamily Paramyxovirinae constitute a large number of highly virulent
human and animal pathogens. The glycoproteins present on these viruses are responsible for mediating
host cell attachment and fusion and are key targets for the design of antiviral entry inhibitors. In the
present review, we discuss recent structural studies which have led to a better understanding of the various
mechanisms by which different paramyxoviruses use their attachment glycoproteins to hijack specific
protein and glycan cell-surface receptors to facilitate viral entry. It is observed that the paramyxovirus
attachment glycoprotein consists of a conserved overall structure which includes an N-terminal six-bladed
β-propeller domain which is responsible for cell receptor binding. Crystal structures of this domain from
different biomedically important paramyxoviruses, including measles, Nipah, Hendra, Newcastle disease
and parainfluenza viruses, alone and in complex with their functional cell-surface receptors, demonstrate
three contrasting mechanisms of receptor engagement that paramyxoviruses have evolved to confer
discreet protein- and glycan-receptor specificity. This structural information highlights the adaptability of the
paramyxovirus attachment glycoprotein surface and the potential for the emergence of new and potentially
harmful viruses in human hosts.
Paramyxovirus entry
The subfamily Paramyxovirinae belongs to the Paramyxovi-
ridae family and includes five genera: Rubulavirus, Avu-
lavirus, Respirovirus, Henipavirus and Morbillivirus. This
group of viruses constitutes over 31 vertebrate-borne viruses,
many of which are currently of worldwide biomedical
importance. The negative-polarity single-stranded genome
of viruses within this group encodes seven to nine proteins,
four of which are structural: the attachment glycoprotein,
F (fusion) glycoprotein (a class-I fusion architecture [1]),
matrix protein and nucleocapsid protein. The attachment
and F glycoproteins extend outwards from a surrounding
lipid bilayer envelope and assemble as a higher-order
hetero-oligomer. This glycoprotein complex orchestrates
the paramyxoviral entry process of cellular attachment and
subsequent pH-independent fusion of the host cell and viral
membranes, ultimately leading to the release of viral RNA
into the host cell.
The ability of a paramyxovirus to undergo host
cell entry is highly dependent on the capacity of the
attachment glycoprotein to specifically bind receptors
which are expressed on the cell surface. As a result of
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the varying specificity of paramyxoviruses for different
receptors, the attachment glycoprotein falls into one
of three classes: HN (haemagglutinin-neuraminidase), H
(haemagglutinin) or G (attachment glycoprotein). HN glyco-
proteins [e.g. from NDV (Newcastle disease virus)] have
the ability to haemagglutinate red blood cells and cleave
sialic acid linkages (to protect against viral self-agglutination),
whereas H glycoproteins [e.g. from MV (measles virus)]
haemagglutinate, but lack neuraminidase activity, and G
glycoproteins [e.g. from NiV (Nipah virus)] lack both
haemagglutination and neuraminidase activity. The cell-
surface receptors utilized by paramyxoviruses for attachment
can be either protein or carbohydrate. HN glycoproteins
such as PIVs (parainfluenza viruses) and NDV [2] use sialic
acid (N-acetylneuraminic acid), a terminal saccharide present
on cell glycans. H and G glycoproteins, on the other hand,
use glycoprotein cell-surface receptors such as CD46 [3,4]
and SLAM (signalling lymphocyte activation molecule) (or
CD150) [5,6] for MV, and ephrinB2 and ephrinB3 for the
highly pathogenic NiV and HeV (Hendra) viruses [7–9].
In the present review, we focus on the recent structural
studies which have revealed a conserved basic architecture
of the paramyxovirus attachment glycoprotein as well as the
differential mechanisms by which each class of attachment
glycoprotein is known to interact with its host cell receptor.
HN glycoprotein structure
As for all classes of paramyxovirus attachment glycoproteins,
HNs have a type-II integral membrane protein architecture
consisting of an N-terminal cytoplasmic and transmembrane
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Figure 1 Representative structures of the three Paramyxovirinae attachment glycoprotein classes in complex with their human
cell-surface receptors
All attachment glycoproteins are superimposed in the same orientation and shown as cartoons coloured as a rainbow with
the N-terminus in blue and the C-terminus in red. (A) NDV-HN in complex with DANA at the primary receptor-binding site
(1) and thiosialoside at the putative secondary receptor-binding site (2) (PDB code 1USX). DANA and thiosialoside are shown
as sticks with carbon atoms coloured grey, oxygen atoms red, nitrogen atoms blue and sulfur atoms yellow. (B) MV-H in
complex with the SCR1 and SCR2 domains of CD46 (PDB code 3INB). CD46 is shown as a grey cartoon. (C) NiV-G in complex
with the receptor-binding domain of ephrinB2 (PDB code 2VSM). EphrinB2 is shown as a grey cartoon.
region (∼70 amino acids), a stalk region which has been
implicated as being responsible for glycoprotein oligo-
merization and interaction with the F glycoprotein (∼100
amino acids), and a six-bladed β-propeller domain which
is involved in receptor binding (∼400 amino acids)
(Figures 1–3).
Crystal structures of the globular HN receptor-binding
β-propeller have been solved from three viral species: NDV
(an Avulavirus) [10,11], PIV5 (a Rubulavirus) [12] and PIV3
(a Respirovirus) [13]. The β-propeller consists of six blades
(each consisting of four antiparallel β-strands) assembled
in a torroidal arrangement around a central axis and is
well conserved among all the three known HN structures
[average of 1.6 Å (1 Å = 0.1 nm) r.m.s.d. (root mean
square deviation) between equivalent Cα positions] [12].
In the case of PIV5-HN, the glycoprotein was crystallized in
the presence of the tetramerization-inducing stalk domain
(amino acids 37–117). However, no electron density for
this region was observed, suggesting that its structure may
be conformationally variable in the protein crystal [12].
Crystallized NDV-HN and PIV3-HN constructs, on the
other hand, lacked the stalk domain and were demonstrated
to be monomeric in solution [10,11,13]. Despite differences
between the constructs and solution-state measurements,
NDV-HN (both a dimer and tetramer were observed),
PIV3-HN (dimer observed) and PIV5-HN (tetramer)
crystals were composed of either dimers or tetramers,
where the overall mode of association between β-propeller
subunits was broadly comparable, suggestive of a common
mode of HN glycoprotein association on the envelope
surface [12].
HN glycoprotein receptor binding
The receptor-binding site of the viral HN is located deep
in the centre of the β-propeller (Figures 1A and 2A). The
crystal structures of NDV-HN, PIV3-HN and PIV5-HN
have all been solved in complex with carbohydrate ligands
including sialic acid (β-anomer), the inhibitors DANA (2,3-
dehydro-2-deoxy-N-acetylneuraminic acid) and Zanamivir
(4-guanidino-Neu5Ac2en), and the trisaccharide sialyl-
lactose [10–13]. These structures have demonstrated that the
receptor-binding sites in paramyxoviral HN glycoproteins
rely on a surface of seven well-conserved residues [10–13].
In contrast with the rigid sialic acid-binding cleft observed in
influenza-HN [14–16], the binding site in PIV3-HN, PIV5-
HN and NDV-HN is architecturally plastic and adaptable
to different sialic acid analogues. This plasticity is manifested
in the movement of not only receptor-binding residues, but
also entire loops located in the first and sixth blades of the
β-propeller. It was suggested by Crennell et al. [10] that
this protein flexibility is required for the multifunctional
properties of the HN-binding site as it is responsible for
binding and destroying its carbohydrate receptor as well as
activating the associated F glycoprotein [10]. Thus the distinct
conformational states observed in these structures may reflect
a switch between a receptor engagement and an activated
catalytic state [10,11].
The hypothesis of a multifunctional HN-binding site
was later confirmed by site-directed mutagenesis of amino
acids in the carbohydrate-binding cavity of NDV-HN which
resulted in reduced enzymatic activity, carbohydrate-binding
affinity and overall fusogeneity of the associated NDV-F
glycoprotein [17,18]. A second sialic acid site has also been
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Figure 2 Comparison of the receptor-binding sites for HN, H and G Paramyxovirinae attachment glycoproteins
In the top panel, (A) NDV-HN (PDB code 1USX), (B) MV-H (PDB code 3INB) and (C) NiV-G (PDB code 2VSM) are shown
as β-propellers and are coloured as in Figure 1. The β-propeller blades are numbered from one to six according to
standard nomenclature [10]. In the bottom panels, surface representations for each of the molecules are shown. Cell-surface
receptor-binding footprints were calculated using PDBsum [48] and plotted on to the surface of each viral glycoprotein. In
(A), the DANA-binding site on NDV-HN is shown in orange and the thiosialoside-binding site is shown in blue. In (B), the
CD46-binding site on MV-H is shown in red. In (C), the ephrinB2-binding site is shown in green.
observed near the dimerization interface of NDV-HN β-
propellers (Figures 1A and 2A). The presence of such a
secondary binding site has been suggested to be important for
maintaining virus cell avidity during structural changes which
may occur to the attachment–fusion complex following initial
receptor engagement [11]. This binding site, however, has not
been observed in the analogous PIV3-HN and PIV5-HN
structures, and, as a result, its functionality with regard to all
Paramyxovirinae HN glycoproteins is still to be confirmed
[12,13].
Attachment by H glycoproteins
In contrast with sialic acid-binding HN glycoproteins, G and
H glycoproteins attach to protein cell-surface receptors using
a carbohydrate-independent mechanism. Morbilliviruses
C©The Authors Journal compilation C©2010 Biochemical Society
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Figure 3 Structural phylogeny of representative receptor-binding β-propeller domains from the Paramyxovirinae
Superpositions were performed using SHP [49] to optimize the probability of equivalence between Cα residue pairs. Following
alignment, a pairwise evolutionary distance matrix was constructed and converted into an unrooted tree using PHYLIP [50].
PDB codes are shown in parentheses.
such as MV have two established functional receptors: CD46
and SLAM [3–6]. CD46 is an ubiquitously expressed type-
I membrane glycoprotein consisting of four extracellular
SCR (short consensus repeat) domains (SCR1–SCR4) and is
involved in the negative regulation of complement activation
[19]. The two most N-terminal of these (SCR1 and SCR2)
have been predicted to be involved in MV-H binding [20].
SLAM is a type-I membrane glycoprotein and is expressed
on haemopoietic cells such as B-cells, T-cells, dendritic cells
and macrophages [21,22]. The extracellular portion of SLAM
consists of two Ig-like domains, the most N-terminal of
which is suspected to be involved in MV-H binding [23,24].
The usage of SLAM and CD46 receptors, however, differs
between MV strains. Whereas Edmonston and related vaccine
strains have been shown to use both SLAM and CD46 as
entry receptors, SLAM, but not CD46, has proved to be the
receptor for the majority of wild-type isolates [3,4,25,26].
It has been suggested that MV utilizes additional functional
ligands, including an as yet unidentified receptor on polarized
epithelial cells [27,28]. Another recently identified receptor
includes the extracellular matrix metalloproteinase inducer
(CD147/EMMPRIN) which, rather than binding to MV-H,
binds to virion-associated cyclophilin [29]. The capacity of
MV to use these alternative receptors helps to rationalize
the virus’s broad tissue tropism as, in addition to infecting
haemopoietic cells, MV also infects endothelial, epithelial and
neuronal cells [30].
The crystal structure of the unbound C-terminal head
domain of MV-H has been independently determined by
multiple groups [31,32] and reveals that this receptor-binding
domain consists of a six-bladed β-propeller (Figures 1B and
2B) which is most closely related to the β-propeller fold of the
known NDV-HN, PIV3-HN and PIV5-HN glycoprotein
structures. Similar to many of the HN glycoprotein structures
described above, MV-H β-propellers were observed to pack
in a dimeric arrangement [32]. Structural comparison of the
MV-H β-propeller with other HN glycoprotein β-propellers
indicates, however, that there is a large structural divergence
between the Morbillivirus, Avulavirus, Respirovirus and
Rubulavirus attachment glycoproteins (average of 3.2 Å
r.m.s.d. between MV-H and other paramyxoviral HN
glycoproteins over 295 equivalent Cα atoms) (Figure 3)
[32]. These architectural differences are most visible when
looking down the β-propeller fold. Whereas the known
HN structures are quite globular and rounded in shape, the
MV-H propeller has been described to form a more cubic
arrangement [31,32].
H glycoprotein receptor interactions
In the centre of the MV-H β-propeller there is a pocket
analogous to the sialic acid-binding site in HN glycoproteins.
However, despite the presence of this similar HN landscape,
none of the seven essential sialic acid-binding residues is
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conserved. Additionally, the secondary sialic acid-binding
site that is located in one of the NDV-HN structures
[11] is not present, and the equivalent surface appears to
be inaccessible due to the presence of a nearby N-linked
carbohydrate. These data were indicative that morbilliviruses
are not likely to utilize sialic acid as a secondary low-affinity
receptor.
Residues implicated in binding to SLAM, CD46 and the
unknown receptor on polarized epithelial cells have been
mapped on to crystal structures of MV-H and are suggestive
of engagement occurring at the fourth and fifth propeller
blades away from the analogous sialic acid-binding site in HN
glycoproteins [28,31,32]. The structure of MV-H in complex
with the SCR1 and SCR2 domains of CD46 has recently
been determined and confirms some of these predictions
(Figure 1B) [33,34]. In this crystal, MV-H forms a dimer
similar to that observed in unbound MV-H with one CD46
molecule engaging each MV-H. The SCR1 and SCR2 domains
of CD46 were observed to bind to MV-H at the side of the
fourth and fifth blades of the β-propeller burying a surface
of over 2100 Å2 in the protein–protein interface (Figure
2B) [34]. In contrast with the relatively deep sialic acid-
binding site found on HN glycoproteins, the CD46-binding
site, although extensive, is quite shallow. Additionally,
by sequence comparison of SLAM with CD46, Santiago
et al. [34], have identified a Pro-Pro motif in the MV-H-
CD46 interface which is common to both SLAM and CD46
MV-H receptor-binding domains [34]. These observations,
in addition to previous site-directed mutagenesis studies
which compared MV-H-SLAM and MV-H-CD46 specificity
[35,36], indicate that this site may be used to bind both
receptors [34]. Such results underscore the ability of MV-H
to adapt to new cell-surface receptors, and thus new hosts.
Attachment by G glycoproteins
NiV and HeV [collectively referred to as HNV (henipavirus)]
are the sole members of the genus Henipavirus, a group
of viruses which are zoonotic and are associated with high
mortality rates [37]. HNV use the flying fox as a natural
host, and infections have been reported in a number of other
vertebrate species including humans, bats, pigs, cats, dogs and
goats [37,38]. Clinical symptoms of human HNV infection
include fever, hypotension, dizziness, acute encephalitis and
respiratory illness. The time from disease onset to death
is rapid (approx. 7–10 days) [37]. The broad respiratory
and neurological pathology of these viruses can be directly
attributed to their use of ephrinB2 and ephrinB3 as functional
entry receptors during viral attachment [7–9]. EphrinB2
and ephrinB3 are well conserved among HNV-susceptible
species (<95% conserved) and are widely expressed in
many cell types, including neurons, bone, stem cells and
epithelial cells, where they are responsible for fundamental
signalling processes which underlie axon guidance, vascular
development and osteogenesis [39,40].
Henipavirus is the only genus within the Paramyxovirinae
subfamily which attach to their cell-surface receptors through
a G glycoprotein which lacks both haemagglutination
and neuraminidase activity. Multiple structures of the
receptor-binding domains of NiV-G and HeV-G have been
solved in their unbound state and reveal that, similar to
other Paramyxovirinae attachment glycoproteins, the G
glycoprotein consists of a C-terminal six-bladed β-propeller
fold [41–43]. The β-propeller structures superimpose most
closely on to NDV-HN and PIV-HN (average 2.3 Å r.m.s.d.
over 376 Cα atoms) structures, but are much less similar
to that of the cubic arrangement observed in MV-H (3.3 Å
r.m.s.d. over 320 equivalent Cα atoms) (Figure 3) [44]. The
contrasting architectures of HNV attachment glycoproteins
and MV-H reflect the independent evolution of distinct
mechanisms by which these two classes of glycoproteins have
acquired the ability to bind cell-surface protein receptors [44].
G glycoprotein receptor binding
As observed in MV-H, HNV-G has a noticeable cavity
in the centre of the β-propeller which is reminiscent of
the sialic acid-binding site observed in HN glycoproteins.
Despite its presence and the overall structural similarity of
HNV-G to HN glycoproteins, only one of the seven sialic
acid-binding residues which are conserved in the HNs are
present in HNV-G. These observations, analogous to those
made in the MV-H structure [31,32], are suggestive that
this cleft has been left as a vestigial feature marking the
evolutionary departure of Henipavirus from other sialic acid-
binding paramyxoviruses, and that the use of high-affinity
interactions with the low-abundance cell-surface ephrins
removes the need for a receptor releasing enzyme to facilitate
effective virus spread from cell to cell.
Mutagenesis studies have identified putative HNV-G
residues which confer specificity to ephrinB2 and ephrinB3
binding [45–47]. When mapped on to the unbound NiV-G
structure, these sites localize to the top of the β-propeller
near the HN sialic acid-binding site and distant from the
MV-H CD46-binding site. Co-crystal structures of NiV-G
and HeV-G in complex with ephrinB2 confirmed many of
these functional predictions [44]. EphrinB2, which consists
of a Greek key β-barrel fold, engages HeV-G and NiV-G
in nearly identical positions at the centre of the β-propeller,
directly above the analogous HN sialic acid-binding site, in
a 1:1 interaction (Figures 1C and 2C). The relatively shallow
protein–protein interactions between the viral and human
proteins (in comparison with HN–sialic acid interactions)
in these two co-crystal structures are extensive (more than
2600 Å2 of buried surface) and dominated by hydrophobic
contacts between residues in an ephrinB2 (GH) loop and
residues located at the top surface of the β-propeller. Similar
structural information was gained by study of NiV-G in
complex with ephrinB3 [42]. The binding mode of ephrinB3
is very similar to that of ephrinB2, with the exception of
minor residue differences in the ephrinB3 GH loop.
Comparison of bound and unbound structures of NiV-G
and HeV-G also provides evidence for an induced-fit mechan-
ism of ephrin binding, where loops in the first and sixth blades
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of the HNV-G β-propeller undergo conformational changes
upon receptor engagement [41–43]. Such conformational
changes facilitate the formation of an ephrin-binding pocket
which accommodates a phenylalanine residue, Phe120ephrinB2.
Phe120ephrinB2 was confirmed as being crucial to the interaction
by site-directed mutagenesis and binding experiments using
a F120AephrinB2 mutant which was found to be incapable
of binding NiV-G [44]. It is also important to note that
the conformational changes observed between the unbound
and bound HNV-G may also be important for activation
of the fusion mechanism. As in all of the Paramyxovirinae,
the exact mechanism by which HNV-F are activated is
unknown, and it is likely that ephrin-induced conformational
changes of HNV-G may be important for activation of
HNV-F, thereby facilitating fusion of the viral and host
membranes.
Conclusions
In the present review, we have illustrated the various
known mechanisms by which biomedically important viruses
within the Paramyxovirinae subfamily use their envelope-
associated attachment glycoproteins to hijack host cell
receptors to facilitate attachment. Through comparison
of structural data resulting from studies of viruses from
different genera, we observe that all Paramyxovirinae utilize
a receptor-binding six-bladed β-propeller domain to adapt
to their corresponding host cell receptors. Whereas the
sialic acid-binding HN glycoproteins of the avulaviruses,
rubulabiruses and respiroviruses rely on a strictly conserved
and multifunctional pocket deep in the centre of the β-
propeller that can be used for both glycan binding and
cleavage, protein-binding Morbillivirus H and Henipavirus
G glycoproteins utilize shallow, yet extensive, single-purpose
binding sites.
Structural comparison of H and G glycoprotein β-
propellers reveals, however, that, despite having common
protein-binding capacities, these two classes of attachment
glycoprotein are markedly different in both their architecture
and mode of receptor engagement. The six-bladed β-
propeller of MV-H, for example, is more cubic in shape
than its more globular HNV-G counterpart. Equally, MV-H
engages its CD46 and SLAM entry receptors at overlapping
binding sites which lie along the outside of the β-propeller,
whereas HNV-G binds to ephrinB2 and ephrinB3 at the top
and centre of the β-propeller.
Assuming a common evolutionary Paramyxovirus pre-
cursor, the structural and functional differences of the
HN, H and G glycoproteins studied in the present review
highlight the wide mechanistic diversity of the Paramyxovirus
attachment. This underscores the ability of the six-bladed β-
propeller scaffold to adapt to different host cell receptors and
in turn suggests that this architecture provides a molecular
platform by which potentially dangerous but currently
unknown paramyxoviruses could change cellular tropism and
thus emerge in new hosts.
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